SEARCH

SEARCH BY CITATION

References

  • Bear, M.R. (1998) Assessment of minimal residual disease in patients with acute leukemia. Current Opinion in Oncology, 10, 1722.
  • Biondi, A., Yokota, S., Hansen-Hagge, T.E., Rossi, V., Giudici, G., Maglia, O., Basso, G., Tell, C., Masera, G. & Bartram, C.R. (1992) Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukaemia, 6, 282288.
  • Campana, D. & Coustan-Smith, E. (1999) Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry, 38, 139152.
  • Campana, D. & Pui, C.H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 14161434.
  • Ciudad, J., Orfao, A., Vidriales, B., Macedo, A., Martinez, A., Gonzalez, M., Lopez-Berges, M.C., Valverde, B. & San Miguel, J.F. (1998a) Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica, 83, 10691075.
  • Ciudad, J., San Miguel, J.F., López-Berges, M.C., Vidriales, B., Valverde, B., Ocqueteau, M., Mateos, G., Caballero, M.D., Hernandez, J., Moro, M.J., Mateos, M.V. & Orfao, A. (1998b) Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. Journal of Clinical Oncology, 16, 37743781.
  • Coustan-Smith, E., Behm, F.G., Sanchez, J., Boyett, J.M., Hancock, M.L., Raimondi, S.C., Rubnitz, J.E., Rivera, G.K., Sandlund, J.T., Pui, C.H. & Campana, D. (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia. Lancet, 351, 350354.
  • Coustan-Smith, E., Sancho, J., Hancock, M.L., Boyett, J.M., Behm, F.G., Raimondi, S.C., Sandlund, J.T., Rivera, G.K., Rubnitz, J.E., Ribeiro, R.C., Pui, C.H. & Campana, D. (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood, 96, 26912696.
  • Van Dongen, J.J.M., Macintyre, E.A., Delabesse, E., Rossi, V., Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., Parreira, A., Gameiro, P., Diaz, M.G., Malec, M., Langerak, A.W., San Miguel, J.F. & Biondi, A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberration in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukaemia, 13, 19011928.
  • Dworzak, M.N., Froschl, G., Printz, D., Mann, G., Potschger, U., Muhlegger, N., Fritsch, G., Gadner, H. & Austrian Berlin–Frankfurt–Munster Study Group (2002) Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood, 99, 19521958.
  • Foroni, L., Harrison, C.J., Hoffbrand, A.V. & Potter, M.N. (1999) Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis. British Journal of Haematology, 105, 724.
  • Freeman, W.M., Walker, S.J. & Vrana, K.E. (1999) Quantitative RT-PCR: pitfalls and potential. Biotechniques, 26, 112125.
  • Garcia Vela, J.A., Monteserin, M.C., Delgado, I., Benito, L. & Ona, F. (2000) Aberrant immunophenotypes detected by flow cytometry in acute lymphoblastic leukemia. Leukaemia and Lymphoma, 36, 275284.
  • Gibson, U.E.M., Heid, C.A. & Williams, P.M. (1996) A novel method for real-time quantitative RT-PCR. Genome Research, 6, 9951001.
  • Griesinger, F., Pirò-Noack, M., Kaib, N., Falk, M., Renziehausen, A., Troff, C., Grove, D., Schnittger, S., Buchner, T., Ritter, J., Hiddemann, W. & Wormann, B. (1999) Leukemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukemia: detection in remission marrow predicts outcome. British Journal of Haematology, 105, 241255.
  • Heid, C.A., Stevens, J., Livak, K.J. & Williams, P.M. (1996) Real-time quantitative PCR. Genome Research, 6, 986994.
  • Hosler, G.A., Bash, R.O., Bai, X., Jain, V. & Scheuermann, R.H. (1999) Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. American Journal of Pathology, 154, 10231035.
  • Jennings, D.C. & Foon, K.A. (1997) Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood, 90, 28632892.
  • Krampera, M., Perbellini, O., Maggioni, A., Scognamiglio, F., Todeschini, G. & Pizzolo, G. (2001) Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia. Haematologica, 86, 307308.
  • Martuza, F.Y., Papaioannou, M., Moreira, I.M., Coyle, L.A., Gameiro, P., Gandini, D., Prentice, H.G., Goldstone, A., Hoffbrand, A.V. & Foroni, L. (2002) Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. Journal of Clinical Oncology, 20, 10941104.
  • Neale, G.A.M., Coustan-Smith, E., Pan, Q., Chen, X., Gruhn, B., Stow, P., Behm, F.G., Pui, C.H. & Campana, D. (1999) Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukaemia, 13, 12211226.
  • Pizzolo, G., Vincenzi, C., Nadali, G., Veneri, D., Vinante, F., Chilosi, M., Basso, G., Connelly, M.C. & Janossy, G. (1994) Detection of membrane and intracellular antigens by flow cytometry following Ortho PermeaFix fixation. Leukaemia, 8, 672676.
  • Porwit-McDonald, A., Bjorklund, E., Lucio, P., Van Lochem, E.G., Mazur, J., Parreira, A., Van Den Beemd, M.W., Van Wering, E.R., Baars, E., Gaipa, G., Biondi, A., Ciudad, J., Van Dongen, J.J., San Miguel, J.F. & Orfao, A. (2000) BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL). Leukaemia, 14, 816825.
  • Pui, C.H. & Campana, D. (2000) New definition of remission in childhood acute lymphoblastic leukemia. Leukaemia, 14, 783785.
  • Radich, J.P. (2000) Clinical applicability of the evaluation of minimal residual disease in acute leukemia. Current Opinion in Oncology, 12, 3640.
  • Rivera, G.K. & Crist, W.M. (1995) Acute lymphoblastic leukemia. In: Blood: Principles and Practice of Hematology (ed. by R.I.Handin, T.P.Stossel & S.E. Lux), pp. 743759. J.P. Lippincott, Philadelphia.
  • San Miguel, J.F., Ciudad, J., Vidriales, M.B., Orfao, A., Lucio, P., Porwit-MacDonald, A., Gaipa, G., Van Wering, E. & Van Dongen, J.J. (1999) Immunophenotypical detection of minimal residual disease in acute leukemia. Critical Reviews in Oncology and Hematology, 32, 175185.
  • Sievers, E.L. & Radich, J.P. (2000) Detection of minimal residual disease in acute leukemia. Current Opinion in Hematology, 7, 212216.
  • Syrjälä, M., Anttila, V.J., Ruutu, T. & Jansson, S.E. (1994) Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens. Leukaemia, 8, 15641570.